Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for knee osteoarthritis with osteoporosis
jRCTs051180095Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Trial of teriparatide and alfacalcidol in knee osteoarthritis (OA) and osteoporosis (2 arms), sponsored by Asahi Kasei Corporation. Primary endpoint: Disease progression by X ray. Started Oct 2018; status: completed.
02
Drugs
teriparatidealfacalcidol
03
Conditions
knee osteoarthritis (OA)osteoporosis
Beyond the preview
Go deeper on jRCTs051180095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180095.